Drugs / FB1003
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06343714 | Apr 2024 → Feb 2026 overdue | — | 4B Technologies Limited | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FB1003 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06343714 ↗ |
| Route | Subcutaneous | “Subcutaneous (SC) injection” NCT06343714 ↗ |